CASC9 and lncRNA UCA1 in drug resistance in NSCLC
Mechanisms of CASC9 and lncRNA UCA1 in drug resistance in NSCLC. (A) CASC9 suppresses the tumor suppressor DUSP1 by recruiting histone methyltransferase EZH2 and increasing the resistance to gefitinib. (B) LncRNA UCA1 acts as an endogenous competitive RNA that can bind with miR-143 to regulate the expression of FOSL2. In addition, lncRNA UCA1 increases resistance to cisplatin through the UCA1/miR-495/NRF2 signaling pathway. CASC9, candidate tumor susceptibility gene 9; lncRNA, long non-coding RNA; UCA1, lncRNA urothelial carcinoma-associated; NSCLC, non-small cell lung cancer; DUSP1, dual specificity phosphatase 1; miR, microRNA; EZH2, zeste homolog 2
Publication
Long non-coding RNAs as potential therapeutic targets in non-small cell lung cancer (Review) (2023) Peiyu Tang, et al. Int J Mol Med. 2023 Aug;52(2). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CASC9 | CASC9 | ncbigene_symbol | CASC9 | 101805492 |
| Homo sapiens | Primates | Lnc | LNC | ncbigene_synonym | TMC6 | 11322 |
| Homo sapiens | Primates | Lnc | LNC | ncbigene_synonym | SCARNA10 | 692148 |
| Homo sapiens | Primates | UCA1 | UCA1 | ncbigene_symbol | UCA1 | 652995 |
| Homo sapiens | Primates | MiR-495 | MIR-495 | ncbigene_synonym | MIR495 | 574453 |
| Homo sapiens | Primates | MiR-143 | MIR-143 | ncbigene_synonym | MIR143 | 406935 |
| Homo sapiens | Primates | FOSL2 | FOSL2 | ncbigene_symbol | FOSL2 | 2355 |
| Homo sapiens | Primates | EZH2 | EZH2 | ncbigene_symbol | EZH2 | 2146 |
| Homo sapiens | Primates | DUSP1 | DUSP1 | ncbigene_symbol | DUSP1 | 1843 |
| Homo sapiens | Primates | DUSP1 | DUSP1 | ncbigene_synonym | DUSP12 | 11266 |
| Homo sapiens | Primates | NRF2 | NRF2 | ncbigene_synonym | GABPA | 2551 |
| Homo sapiens | Primates | NRF2 | NRF2 | ncbigene_synonym | NFE2L2 | 4780 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|